NMPA accepts clinical trial application for monkeypox vaccine

chinadaily.com.cn | Updated: 2023-07-14 19:44

Share - WeChat

The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.

Photo

Pipeline arch bridge connects Jiayan water project in Guizhou mountains

Zhejiang activates emergency response as Typhoon Dolphin approaches

County in Jilin transforms saline land into crab, water bamboo farms

Shenzhou XXI crew meets press after returning from space

Smart Dragon 3 rocket successfully launches 2 satellites from sea

PLA Air Force cadets arrive for training aboard Y-20

Latest

State Council News

A look at China's economy in H1 of 2026

Exclusive

Taiwan investor helps cross-Strait startups thrive in Beijing

Taiwan youth putting down roots in Daliang Mountains

Qinghai-Xizang Railway: 20 years on

Newsmaker

Chinese scientists honored with American Meteorological Society awards

Space weather scientist honored

Special Coverage

105th founding anniv. of the CPC

75th anniv. of Xizang's peaceful liberation

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349